honluten is a synthetic bioregulatory peptide associated with liver tissue regulation and hepatic cellular health. It belongs to the learn of short peptides known as bioregulators, which are designed to influence gene expression and cellular function in a tissue-specific manner. Chonluten is primarily studied for its potential role in supporting liver cell metabolism and repair rather than acting as a detoxifying agent or medication.
Chonluten is not an approved pharmaceutical treatment and is classified as a research compound.
What Is Chonluten
Chonluten is a short-chain peptide derived from amino acid sequences believed to be involved in liver tissue signaling. Bioregulator peptides differ from hormones and enzymes in that they do not force immediate physiological changes. Instead, they are thought to help normalize cellular processes within a specific organ.
This liver-targeted regulatory design is the defining characteristic of Chonluten.
How Chonluten Works
Chonluten is believed to act at the level of gene expression within hepatocytes, the primary functional cells of the liver. By influencing how certain genes are expressed, it may help support metabolic balance, cellular repair mechanisms, and resilience to oxidative or metabolic stress.
Rather than directly stimulating detoxification pathways or altering liver enzymes acutely, Chonluten’s proposed role is regulatory and supportive over time.
Structure
Molecular Formula: C11H17N3O8
Molecular Weight: 319.27 g/mol
PubChem CID: 194641
CAS No: 75007-24-8
Alternative Names: T-34 tripeptide, EDG
Source: PubChem
Mechanistic Research Context
Experimental research on short regulatory peptides, including di-, tri-, and tetrapeptides, demonstrates that these molecules can influence lifespan-associated biomarkers, tumor-development parameters, and transcriptional stability in animal models. These effects are interpreted through peptide-mediated regulation of gene expression, chromatin accessibility, and apoptosis-associated signaling networks in preclinical systems.
Multiple studies indicate that short peptides can influence gene expression through several regulatory layers, including epigenetic mechanisms such as DNA methylation. Computational modeling and in-vitro binding assays suggest that certain short peptides may traverse cellular and nuclear membranes and interact directly with DNA regulatory regions, including promoters and suppressor elements, thereby influencing transcriptional activity.
Research programs associated with the St. Petersburg Institute of Bioregulation and Gerontology have contributed extensively to this field. Within these experimental frameworks, Chonluten has been examined as one of multiple peptide regulators used to investigate peptide–DNA interactions and downstream transcriptional control in cellular and animal models.
Respiratory Tissue Gene-Expression Models
Preclinical studies report tissue-selective transcriptional responses to Chonluten in respiratory epithelial models. These investigations focus on gene-expression changes affecting mucosal-barrier components, extracellular-matrix regulators, and oxidative-stress-response genes under experimentally induced inflammatory or hypoxic conditions.
Genes evaluated in these models include transcription factors and stress-response regulators such as c-FOS, heat-shock proteins (e.g., HSP70), superoxide dismutase (SOD), cyclooxygenase-2 (COX-2), tumor necrosis factor-alpha (TNF-α), and related antioxidant-pathway components. These genes are commonly used as molecular readouts of cellular stress adaptation, proliferation signaling, and redox balance in laboratory research.
Inflammation-Associated Signaling Pathways
Within experimental inflammatory models, Chonluten has been evaluated for its association with modulation of transcriptional programs linked to cytokine signaling, oxidative-stress regulation, and epithelial-barrier dynamics. Interpretation of these findings remains limited to controlled laboratory systems and does not imply translational or clinical outcomes.
Gastrointestinal Tissue Models
Additional studies examine Chonluten-associated transcriptional effects in gastrointestinal tissue models, with emphasis on vascular signaling, inflammatory-response genes, and oxidative-stress markers measured in preclinical experimental designs.
Research Summary
Collectively, Chonluten is characterized in the literature as a short peptide regulator of gene expression with tissue-specific transcriptional effects in respiratory and gastrointestinal experimental models. Its research utility lies in mechanistic studies of peptide-mediated transcriptional regulation, epigenetic control, and stress-response signaling in vitro and in animal systems.



Reviews
There are no reviews yet.